2023
DOI: 10.1016/j.mtchem.2022.101303
|View full text |Cite
|
Sign up to set email alerts
|

Tumor cell surface modification with immuno-amplified nanoparticles to enhance cancer immunotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 38 publications
0
1
0
Order By: Relevance
“…By incorporating specific targeting compounds, such as antibodies or aptamers, into their membranes, their delivery accuracy can be significantly improved [16][17][18] . New methods, such as fusogenic liposomes with the ability to merge directly with the cell cytoplasm as well as other functionalized and triggerable lipid vesicles are coming increasingly into view [19][20][21][22][23][24] . Despite the numerous reports of promising liposome approaches, there is no complete understanding of the exact process of the bilayer manipulation of liposomes.…”
mentioning
confidence: 99%
“…By incorporating specific targeting compounds, such as antibodies or aptamers, into their membranes, their delivery accuracy can be significantly improved [16][17][18] . New methods, such as fusogenic liposomes with the ability to merge directly with the cell cytoplasm as well as other functionalized and triggerable lipid vesicles are coming increasingly into view [19][20][21][22][23][24] . Despite the numerous reports of promising liposome approaches, there is no complete understanding of the exact process of the bilayer manipulation of liposomes.…”
mentioning
confidence: 99%